Cargando…
Novel Therapies in Takayasu Arteritis
Takayasu Arteritis (TAK) is a large-vessel vasculitis that preferentially involves the aorta and its primary branches. Cardiac involvement is frequent in TAK and is a major determinant of the patient's outcome. Glucocorticoids (GC) are the mainstay of therapy for TAK, with high doses of GC effe...
Autores principales: | Regola, Francesca, Uzzo, Martina, Toniati, Paola, Trezzi, Barbara, Sinico, Renato Alberto, Franceschini, Franco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790042/ https://www.ncbi.nlm.nih.gov/pubmed/35096902 http://dx.doi.org/10.3389/fmed.2021.814075 |
Ejemplares similares
-
Novel Targets for Drug Use in Eosinophilic Granulomatosis With Polyangiitis
por: Uzzo, Martina, et al.
Publicado: (2021) -
Long-term treatment with tocilizumab in giant cell arteritis: efficacy and safety in a monocentric cohort of patients
por: Regola, Francesca, et al.
Publicado: (2020) -
Scleritis in Takayasu Arteritis
por: Chittipolu, Swetha, et al.
Publicado: (2023) -
Takayasu Arteritis Mimicking Phlegmon
por: Taira, Yuki, et al.
Publicado: (2022) -
Advances in Takayasu arteritis: An Asia Pacific perspective
por: Danda, Debashish, et al.
Publicado: (2022)